Humphrey Shannon, Jacky Birgitte, Gallagher Conor J
*Carruthers & Humphrey Cosmetic Dermatology, Vancouver, British Columbia, Canada; †Department of Dermatology, University of British Columbia, Vancouver, British Columbia, Canada; ‡Research and External Scientific Innovation, Allergan plc, Irvine, California; §Medical Affairs, Allergan plc, Irvine, California.
Dermatol Surg. 2017 Dec;43 Suppl 3:S244-S251. doi: 10.1097/DSS.0000000000001404.
Botulinum toxin Type A (BoNTA) is the gold standard for the treatment of dynamic rhytides in the face. Recently, clinical observation suggests that individuals who receive regular injections of BoNTA experience ongoing wrinkle reduction and improvements in overall skin quality not observed in those treated sporadically.
To review scientific evidence of qualitative changes in the skin and the possibility of indirect or direct effects on fibroblasts affecting fibroblast activity, including collagen production, after repeated treatment with BoNTA.
We examined the literature for supporting evidence of the effect of repeated treatment cycles on wrinkle reduction and skin quality; histological changes in collagen structure; alterations in biomechanical features of the skin; and potential fibroblastic response.
Apparent cumulative improvement on wrinkle reduction and additional skin quality attributes with regular BoNTA treatments suggests an ongoing process of dermal repair. Clinical observation suggests that BoNTA injections stimulate collagen production and lead to a reorganization of the collagen network within the extracellular matrix, which in turn may produce improvements in features associated with more youthful skin. Moreover, evidence suggests that BoNTA may have a direct or indirect effect on fibroblast activity.
Clinical observation of progressive wrinkle reduction and qualitative improvements in a number of skin attributes that accumulate with more frequent injections of BoNTA suggest an ongoing process of repair leading to prolonged and cumulative effects.
A型肉毒毒素(BoNTA)是治疗面部动态皱纹的金标准。最近,临床观察表明,接受定期注射BoNTA的个体皱纹持续减少,整体皮肤质量改善,而偶尔接受治疗的个体则未观察到这种情况。
回顾重复使用BoNTA治疗后皮肤质量变化的科学证据,以及对成纤维细胞产生间接或直接影响从而影响成纤维细胞活性(包括胶原蛋白生成)的可能性。
我们查阅文献,寻找支持重复治疗周期对减少皱纹和改善皮肤质量的效果、胶原蛋白结构的组织学变化、皮肤生物力学特征改变以及潜在成纤维细胞反应的证据。
定期使用BoNTA治疗在减少皱纹和改善其他皮肤质量指标方面有明显的累积改善,提示存在持续的真皮修复过程。临床观察表明,BoNTA注射可刺激胶原蛋白生成,并导致细胞外基质内胶原蛋白网络的重组,这反过来可能改善与更年轻肌肤相关的特征。此外,有证据表明BoNTA可能对成纤维细胞活性有直接或间接影响。
临床观察发现,随着BoNTA注射频率增加,皱纹逐渐减少,多项皮肤指标质量改善,提示存在持续的修复过程,可产生长期累积效应。